Amgen Inc. Profile Avatar - Palmy Investing

Amgen Inc.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…

Drug Manufacturers - General
US, Thousand Oaks [HQ]

Lobbying Analysis

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
2023 4 $6,000,000 LD-2 : 01/17/24
2023 4 $6,000,000 LD-2 : 01/17/24
2023 4 $6,000,000 LD-2 : 01/16/24
2023 4 $6,000,000 LD-2 : 01/15/24
2023 4 $5,000,000 LD-2 : 01/13/24

Get PRO Today

With PRO you will unlock 13 more lobbying disclosures for Amgen Inc.

End of AMGN's Analysis
CIK: 318154 CUSIP: 031162100 ISIN: US0311621009 LEI: - UEI: -
Secondary Listings